Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DCG-004 | Glycyrrhizic acid Featured |
>98%,Standard References
More description
|
![]() |
DCF-003 | Lycopene Featured |
>98%,Standard References
More description
|
![]() |
DCY-021 | Folic acid Featured |
>98%,Standard References
More description
|
![]() |
DCH-004 | Magnolol Featured |
>98%,Standard References
More description
|
![]() |
DCJ-038 | 6-Shogaol Featured |
>98%,Standard References
More description
|
![]() |
DCT-015 | Melatonine Featured |
>98%,Standard References
More description
|
![]() |
DCZ-244 | 5-Hydroxy-1,4-naphthalenedione(Juglone) Featured |
>98%,Standard References
More description
|
![]() |
DC8534 | α-Amyloid Precursor Protein Modulator(TPPB) Featured |
α-Amyloid Precursor Protein Modulator is a cell-permeable benzolactam derived PKC activator (Ki = 11.9 nM for PKCα) that efficiently enhances non-amyloidogenic α-processing of amyloid precursor protein (APP) even at 100 nM in human fibroblast AG06848.
More description
|
![]() |
DC46355 | γ-Terpinene |
γ-Terpinene, a monoterpene, is an orally active antioxidant compound which can scavenge radicals directly. γ-Terpinene has potent antinociception activity.
More description
|
![]() |
DC20928 | CRT0066101 Featured |
A potent, specific, orally active pan-PKD (protein kinase D) inhibitor with biochemical IC50 of 1, 2.5 and 2 nM for PKD1, 2, and 3 respectively.
More description
|
![]() |
DC12202 | Pradefovir mesylate (Remofovir mesylate) Featured |
Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a Km of 60 μM.
More description
|
![]() |
DC33076 | NRC-2694 Featured |
NRC-2694 is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors.
More description
|
![]() |
DC23376 | KDM5-C70 Featured |
KDM5-C70 is the cell-permeable derivative of KDM5-C49, potent, selective and cell permeable KDM5 inhibitor with IC50 of 0.3, 0.3 and 0.58 uM for KDM5A, B and C, respectively.
More description
|
![]() |
DC20650 | AKI603 Featured |
AKI-603 is a novel small molecule Aurora A kinase inhibitor with IC50 of 12.3 nM, also inhibits Aurora B kinase activity to a less extent; disrupts normal spindle structure, and induces cell-cycle arrest; t; suppresses stem cell properties in breast cancer cells, and also suppresses the expression of self-renewal genes (β-catenin, c-Myc, Sox2, and Oct4); reduces xenograft tumor growth after intragastric administration.
More description
|
![]() |
DC45109 | β-Gentiobiose |
β-Gentiobiose (Gentiobiose) is a naturally occurring oligosaccharin with a rapid turnover rate in ripening tomato fruit.
More description
|
![]() |
DC8909 | Maribavir Featured |
Maribavir(GW257406X; BW1263W94; 1263W94) inhibits HCMV replication is by inhibition of an HCMV encoded protein kinase enzyme called UL97 or pUL97.
More description
|
![]() |
DC12075 | U18666A Featured |
U18666A, a cell permeable drug, is a cholesterol synthesis and transport inhibitor.
More description
|
![]() |
DC32221 | CP-70429 Featured |
Sulopenem, also known as CP-70429, is a potent beta-lactamase inhibitor.Sulopenem showed potent antibacterial activity against gram-positive and gram-negative bacteria except Pseudomonas aeruginosa and Xanthomonas maltophilia. CP-70,429 was stable to various types of beta-lactamases except for the enzyme from X. maltophilia and was 16- to 128-fold more active than the other compounds against beta-lactamase-producing strains of Enterobacter cloacae and Citrobacter freundii.
More description
|
![]() |
DC32816 | Cytosporone B Featured |
Cytosporone B is the first naturally occurring agonist for nuclear orphan receptor Nur77. The molecule binds with high affinity (IC50=0.278 nM) to the ligand-binding domain of Nur77 and stimulates Nur77-dependent activities. Nur77 is also involved in glucose homeostasis, where it induces genes involved in gluconeogenesis. Csn-B physically binds to Nur77 and activates its transactivational activity and translocation to mitochondria to induce apoptosis. It inhibits cancer cell proliferation and tumor growth.
More description
|
![]() |
DCQ-020 | Oroxylin A Featured |
>98%,Standard References
More description
|
![]() |
DC4138 | Lixivaptan (VPA-985) Featured |
Lixivaptan is a highly potent, non-peptide, oral capsule that works by reducing the action of a hormone (vasopressin) that blocks fluid excretion.
More description
|
![]() |
DC10539 | POL1 inhibitor(POL1-IN-1) Featured |
CAS 1822358-25-7
More description
|
![]() |
DC21242 | LM11A-31 dihydrochloride Featured |
An orally available, brain penetrant p75NTR ligand that blocks p75-mediated cell death, also increases proliferation and survival of hippocampal neural progenitors.
More description
|
![]() |
DC20243 | AWZ1066S Featured |
AWZ1066S is a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.
More description
|
![]() |
DC20176 | INCB057643 Featured |
INCB057643 is a BET inhibitor that binds to the acetylated lysine recognition motifs found in the BRD of BET proteins, thereby preventing the interaction between the BET proteins and acetylated lysines on histones.
More description
|
![]() |
DC20259 | LML134 Featured |
LML134 (compound 18b) is an orally active and high selective Histamine 3 receptor (H3R) inverse agonist with Kis of 0.3 nM and 12 nM for hH3R cAMP and hH3R bdg. LML134 penetrates the brain rapidly, leading to high H3R occupancy, and disengages its target with a fast kinetic profile. LML134 has the potential for excessive sleep disorders[1].
More description
|
![]() |
DC33614 | KL-1333(NQO1 activator 1) Featured |
KL1333 is an orally available, small organic molecule that reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. KL-1333 Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts.
More description
|
![]() |
DC33576 | LJ570 Featured |
LJ570 is the first PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation. LJ570 is a potent partial agonist of both PPARα and γ subtypes. LJ570 inhibited the Cdk5-mediated phosphorylation of PPARγ at serine 273 that is currently considered the mechanism by which some PPARγ partial agonists exert antidiabetic effects similar to thiazolidinediones, without showing their typical side effects. LJ570 may be useful for treatment of dyslipidemic type 2 diabetes.
More description
|
![]() |
DC33398 | O(6)-Benzylguanine Featured |
O(6)-Benzylguanine is an MGMT inhibitor that prevents the repair of DNA damage induced by chemotherapeutics. It allows apoptosis and other mechanisms of cell death to occur.
More description
|
![]() |
DC24081 | Lyn-IN-1 (Synonyms: Bafetinib analog) Featured |
Lyn-IN-1 is a potent and selective dual Bcr-Abl/Lyn inhibitor..
More description
|
![]() |